+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 1201657-09-1
1201657-09-1,MFCD20230270
Catalog No.:AA000QDI

1201657-09-1 | 1H-Pyrazole, 1-methyl-4-[2-(trimethylsilyl)ethynyl]-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
2 weeks  
$477.00   $334.00
- +
250mg
98%
2 weeks  
$663.00   $464.00
- +
1g
98%
2 weeks  
$1,162.00   $814.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000QDI
Chemical Name:
1H-Pyrazole, 1-methyl-4-[2-(trimethylsilyl)ethynyl]-
CAS Number:
1201657-09-1
Molecular Formula:
C9H14N2Si
Molecular Weight:
178.3064
MDL Number:
MFCD20230270
SMILES:
Cn1ncc(c1)C#C[Si](C)(C)C
Properties
Computed Properties
 
Complexity:
218  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
1  
Rotatable Bond Count:
2  

Downstream Synthesis Route

[1]Heterocycles,2018,vol.96,p.1203-1215

[2]Patent:WO2012/123745,2012,A1.Locationinpatent:Page/Pagecolumn70

[3]JournalofMedicinalChemistry,2013,vol.56,p.10045-10065

[4]Patent:US2013/345181,2013,A1.Locationinpatent:Paragraph0638

[5]Patent:CN107344940,2020,B.Locationinpatent:Paragraph1619;1625-1627

[6]Patent:WO2019/28395,2019,A1.Locationinpatent:Paragraph00221

[7]Patent:WO2017/48702,2017,A1.Locationinpatent:Paragraph001136;001138-001142;001144-001148;001155

[8]JournalofMedicinalChemistry,2011,vol.54,p.6014-6027

[9]Patent:CN103539777,2016,B.Locationinpatent:Paragraph0333;0458;0459

[10]Patent:WO2009/150240,2009,A1.Locationinpatent:Page/Pagecolumn109

[1]CurrentPatentAssignee:INFINITYPHARMACEUTICALSINC-WO2017/48702,2017,A1Locationinpatent:Paragraph001137;001143;001149-001154;001156

[2]Ahlburg,NilsLennart;Doppleb,Olivia;Hillrichs,Kai;Namyslo,JanC.;Hübner,EikeG.;Schmidt,Andreas[Heterocycles,2018,vol.96,#7,p.1203-1215]

[3]CurrentPatentAssignee:ABBVIEINC-WO2011/68899,2011,A1Locationinpatent:Page/Pagecolumn233

[4]CurrentPatentAssignee:CANCERRESEARCHUK-WO2012/123745,2012,A1Locationinpatent:Page/Pagecolumn70-71

[5]Naud,Sébastien;Westwood,IsaacM.;Faisal,Amir;Sheldrake,Peter;Bavetsias,Vassilios;Atrash,Butrus;Cheung,Kwai-MingJ.;Liu,Manjuan;Hayes,Angela;Schmitt,Jessica;Wood,Amy;Choi,Vanessa;Boxall,Kathy;Mak,Grace;Gurden,Mark;Valenti,Melanie;DeHavenBrandon,Alexis;Henley,Alan;Baker,Ross;McAndrew,Craig;Matijssen,Berry;Burke,Rosemary;Hoelder,Swen;Eccles,SuzanneA.;Raynaud,FlorenceI.;Linardopoulos,Spiros;VanMontfort,RobL.M.;Blagg,Julian[JournalofMedicinalChemistry,2013,vol.56,#24,p.10045-10065]

[6]CurrentPatentAssignee:CANCERRESEARCHUK-US2013/345181,2013,A1Locationinpatent:Paragraph0639

[7]CurrentPatentAssignee:FRONTHERAPHARMACEUTICALSLLC-WO2019/28395,2019,A1Locationinpatent:Paragraph00222

[8]CurrentPatentAssignee:SHENZHENDONGYANGGUANGINDUSTRIALDEVELOPMENTCOLTD-CN107344940,2020,BLocationinpatent:Paragraph1619;1628-1630

[9]Flynn,BernardL.;Gill,GurmitS.;Grobelny,DamianW.;Chaplin,JasonH.;Paul,Dharam;Leske,AnnabellF.;Lavranos,TinaC.;Chalmers,DavidK.;Charman,SusanA.;Kostewicz,Edmund;Shackleford,DavidM.;Morizzi,Julia;Hamel,Ernest;Jung,M.Katherine;Kremmidiotis,Gabriel[JournalofMedicinalChemistry,2011,vol.54,#17,p.6014-6027]

[10]CurrentPatentAssignee:INFINITYPHARMACEUTICALSINC-WO2016/54491,2016,A1Locationinpatent:Paragraph00605

[11]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-WO2009/150240,2009,A1Locationinpatent:Page/Pagecolumn109

[1]CurrentPatentAssignee:INFINITYPHARMACEUTICALSINC-WO2017/48702,2017,A1

[2]CurrentPatentAssignee:INFINITYPHARMACEUTICALSINC-WO2017/48702,2017,A1

[3]CurrentPatentAssignee:INFINITYPHARMACEUTICALSINC-WO2017/48702,2017,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1201657-09-1
400877-05-6

400877-05-6

 1107601-70-6

1107601-70-6

 112029-98-8

112029-98-8

 1185299-72-2

1185299-72-2
Building Blocks
More >
Tags:1201657-09-1 Molecular Formula|1201657-09-1 MDL|1201657-09-1 SMILES|1201657-09-1 1H-Pyrazole, 1-methyl-4-[2-(trimethylsilyl)ethynyl]-